{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:04:39Z","timestamp":1790813079226,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/1\/2"],"award-info":[{"award-number":["3\/1\/2"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.urolonc.2024.07.017","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:13:11Z","timestamp":1725927191000},"page":"452.e1-452.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The role of autophagy dysregulation in low and high-grade nonmuscle invasive bladder cancer: A survival analysis and clinicopathological association"],"prefix":"10.1016","volume":"42","author":[{"given":"Anil","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukul Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishwajeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh Kumar","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dakshina","family":"Bisht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhendu","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.urolonc.2024.07.017_bib0001","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/medsci8010015","article-title":"Epidemiology of bladder cancer","volume":"8","author":"Saginala","year":"2020","journal-title":"Medical sciences"},{"issue":"3","key":"10.1016\/j.urolonc.2024.07.017_bib0002","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.urolonc.2024.07.017_bib0003","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3390\/biom11040594","article-title":"The role of androgens and androgen receptor in human bladder cancer","volume":"11","author":"Martinez-Rojo","year":"2021","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.urolonc.2024.07.017_bib0004","doi-asserted-by":"crossref","first-page":"123","DOI":"10.14740\/wjon1210","article-title":"Non-muscle invasive bladder cancer: a review of the current trend in Africa","volume":"10","author":"Cassell","year":"2019","journal-title":"World journal of oncology"},{"issue":"4","key":"10.1016\/j.urolonc.2024.07.017_bib0005","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s13337-021-00742-y","article-title":"Associated pathogenesis of bladder cancer and SARS-CoV-2 infection: a treatment strategy","volume":"32","author":"Singh","year":"2021","journal-title":"Virusdisease"},{"key":"10.1016\/j.urolonc.2024.07.017_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/17588359211039052","article-title":"Novel and emerging approaches in the management of non-muscle invasive urothelial carcinoma","volume":"13","author":"Yassaie","year":"2021","journal-title":"Therapeutic advances in medical oncology"},{"issue":"3","key":"10.1016\/j.urolonc.2024.07.017_bib0007","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4103\/njms.njms_62_22","article-title":"Immunotherapeutic and their immunological aspects: current treatment strategies and agents","volume":"13","author":"Jain","year":"2022","journal-title":"National journal of maxillofacial surgery"},{"issue":"6 Suppl 4","key":"10.1016\/j.urolonc.2024.07.017_bib0008","first-page":"S199","article-title":"The management of BCG failure in non-muscle-invasive bladder cancer: an update","volume":"3","author":"Zlotta","year":"2009","journal-title":"Canadian Urological Association journal\u202f=\u202fJournal de l'Association des urologues du Canada"},{"issue":"3","key":"10.1016\/j.urolonc.2024.07.017_bib0009","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MOU.0000000000000601","article-title":"Trimodality therapy for bladder cancer: modern management and future directions","volume":"29","author":"Pham","year":"2019","journal-title":"Curr Opin Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2024.07.017_bib0010","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1590\/s1677-5538.ibju.2020.99.01","article-title":"Bladder preservation in muscle-invasive bladder cancer: a comprehensive review","volume":"46","author":"Hamad","year":"2020","journal-title":"International braz j urol : official journal of the Brazilian Society of Urology"},{"key":"10.1016\/j.urolonc.2024.07.017_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2023.09.008","article-title":"The relationship between BCG immunotherapy and oxidative stress parameters in patients with nonmuscle invasive bladder cancer","author":"Singh","year":"2023","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.07.017_bib0012","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.euros.2022.02.011","article-title":"Comparative outcomes of primary versus recurrent high-risk non-muscle-invasive and primary versus secondary muscle-invasive bladder cancer after radical cystectomy: results from a retrospective multicenter study","volume":"39","author":"Grossmann","year":"2022","journal-title":"European urology open science"},{"issue":"1","key":"10.1016\/j.urolonc.2024.07.017_bib0013","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1128\/MCB.01082-08","article-title":"Kinase-inactivated ULK proteins inhibit autophagy via their conserved C-terminal domains using an Atg13-independent mechanism","volume":"29","author":"Chan","year":"2009","journal-title":"Mol Cell Biol"},{"issue":"11","key":"10.1016\/j.urolonc.2024.07.017_bib0014","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.bbadis.2011.07.005","article-title":"Molecular machinery of macroautophagy and its deregulation in diseases","volume":"1812","author":"Wong","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.urolonc.2024.07.017_bib0015","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","article-title":"Autophagy: renovation of cells and tissues","volume":"147","author":"Mizushima","year":"2011","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.urolonc.2024.07.017_bib0016","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ncb2757","article-title":"ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase","volume":"15","author":"Russell","year":"2013","journal-title":"Nat Cell Biol"},{"issue":"4","key":"10.1016\/j.urolonc.2024.07.017_bib0017","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4161\/auto.19496","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy","volume":"8","author":"Klionsky","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.urolonc.2024.07.017_bib0018","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev-genet-102808-114910","article-title":"Regulation mechanisms and signaling pathways of autophagy","volume":"43","author":"He","year":"2009","journal-title":"Annu Rev Genet"},{"issue":"5","key":"10.1016\/j.urolonc.2024.07.017_bib0019","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1091\/mbc.e07-12-1257","article-title":"The Atg16L complex specifies the site of LC3 lipidation for membrane biogenesis in autophagy","volume":"19","author":"Fujita","year":"2008","journal-title":"Mol Biol Cell"},{"issue":"6700","key":"10.1016\/j.urolonc.2024.07.017_bib0020","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/26506","article-title":"A protein conjugation system essential for autophagy","volume":"395","author":"Mizushima","year":"1998","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.urolonc.2024.07.017_bib0021","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.urolonc.2024.07.017_bib0022","series-title":"Autophagy and metabolism","first-page":"73","article-title":"Chapter 3 - Tumor cell metabolism and autophagy as therapeutic targets","author":"Poojary","year":"2022"},{"issue":"1","key":"10.1016\/j.urolonc.2024.07.017_bib0023","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12943-020-1138-4","article-title":"Autophagy and autophagy-related proteins in cancer","volume":"19","author":"Li","year":"2020","journal-title":"Mol Cancer"},{"issue":"8","key":"10.1016\/j.urolonc.2024.07.017_bib0024","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","article-title":"Autophagy and autophagy-related pathways in cancer","volume":"24","author":"Debnath","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"10.1016\/j.urolonc.2024.07.017_bib0025","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.3390\/ijms19113466","article-title":"The roles of autophagy in cancer","volume":"19","author":"Yun","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"6762","key":"10.1016\/j.urolonc.2024.07.017_bib0026","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/45257","article-title":"Induction of autophagy and inhibition of tumorigenesis by beclin 1","volume":"402","author":"Liang","year":"1999","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.urolonc.2024.07.017_bib0027","first-page":"429","article-title":"Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours","volume":"30","author":"Miracco","year":"2007","journal-title":"Int J Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.07.017_bib0028","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11033-011-0734-1","article-title":"Decreased expression of Beclin-1 and LC3 in human lung cancer","volume":"39","author":"Jiang","year":"2012","journal-title":"Mol Biol Rep"},{"issue":"6","key":"10.1016\/j.urolonc.2024.07.017_bib0029","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.2353\/ajpath.2010.090872","article-title":"Mammalian target of rapamycin (mTOR) regulates cellular proliferation and tumor growth in urothelial carcinoma","volume":"176","author":"Hansel","year":"2010","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.07.017_bib0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3390\/cancers16010125","article-title":"SIRT1 promotes cisplatin resistance in bladder cancer via beclin1 deacetylation-mediated autophagy","volume":"16","author":"Sun","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.urolonc.2024.07.017_bib0031","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.urolonc.2011.12.016","article-title":"Patterns of autophagy in urothelial cell carcinomas the significance of \u201cstone-like\u201d structures (SLS) in transurethral resection biopsies","volume":"31","author":"Sivridis","year":"2013","journal-title":"Urol Oncol"},{"issue":"7","key":"10.1016\/j.urolonc.2024.07.017_bib0032","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.prp.2013.04.006","article-title":"Beclin 1 and bcl-2 expressions in bladder urothelial tumors and their association with clinicopathological parameters","volume":"209","author":"Baspinar","year":"2013","journal-title":"Pathol Res Pract"},{"issue":"7","key":"10.1016\/j.urolonc.2024.07.017_bib0033","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1091\/mbc.e08-12-1249","article-title":"ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery","volume":"20","author":"Jung","year":"2009","journal-title":"Mol Biol Cell"},{"issue":"1","key":"10.1016\/j.urolonc.2024.07.017_bib0034","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000368848","article-title":"Autophagic markers BECLIN 1 and LC3 are associated with prognosis of multiple myeloma","volume":"134","author":"Jung","year":"2015","journal-title":"Acta Haematol"},{"issue":"6","key":"10.1016\/j.urolonc.2024.07.017_bib0035","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.juro.2014.01.006","article-title":"Inhibition of grade dependent autophagy in urothelial carcinoma increases cell death under nutritional limiting condition and potentiates the cytotoxicity of chemotherapeutic agent","volume":"191","author":"Ojha","year":"2014","journal-title":"J Urol"},{"issue":"12","key":"10.1016\/j.urolonc.2024.07.017_bib0036","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1111\/jcmm.16552","article-title":"Identification of autophagy-related genes signature predicts chemotherapeutic and immunotherapeutic efficiency in bladder cancer (BLCA)","volume":"25","author":"Cao","year":"2021","journal-title":"J Cell Mol Med"},{"issue":"7","key":"10.1016\/j.urolonc.2024.07.017_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166400","article-title":"Role and regulation of autophagy in cancer","volume":"1868","author":"Rakesh","year":"2022","journal-title":"Biochimica et biophysica acta Molecular basis of disease"},{"key":"10.1016\/j.urolonc.2024.07.017_bib0038","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.2147\/OTT.S142149","article-title":"Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer","volume":"10","author":"Tang","year":"2017","journal-title":"OncoTargets and therapy"},{"issue":"3","key":"10.1016\/j.urolonc.2024.07.017_bib0039","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1089\/ars.2013.5371","article-title":"An overview of autophagy: morphology, mechanism, and regulation","volume":"20","author":"Parzych","year":"2014","journal-title":"Antioxid Redox Signaling"},{"issue":"1","key":"10.1016\/j.urolonc.2024.07.017_bib0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","article-title":"Autophagy in the pathogenesis of disease","volume":"132","author":"Levine","year":"2008","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.urolonc.2024.07.017_bib0041","first-page":"71","article-title":"An improvement of the 2^(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis","volume":"3","author":"Rao","year":"2013","journal-title":"Biostatistics, bioinformatics and biomathematics"},{"issue":"2","key":"10.1016\/j.urolonc.2024.07.017_bib0042","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.bjc.6602902","article-title":"mTOR signaling: implications for cancer and anticancer therapy","volume":"94","author":"Petroulakis","year":"2006","journal-title":"British journal of cancer"},{"issue":"6","key":"10.1016\/j.urolonc.2024.07.017_bib0043","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3390\/cancers14061555","article-title":"Emerging roles for mammalian target of rapamycin (mTOR) complexes in bladder cancer progression and therapy","volume":"14","author":"Huan","year":"2022","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.urolonc.2024.07.017_bib0044","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3390\/antiox9050374","article-title":"Maksimovic-Ivanic D. The double-faced role of nitric oxide and reactive oxygen species in solid tumors","volume":"9","author":"Mijatovic","year":"2020","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.urolonc.2024.07.017_bib0045","first-page":"232","article-title":"Interaction of YAP1 and mTOR promotes bladder cancer progression","volume":"56","author":"Xu","year":"2020","journal-title":"Int J Oncol"},{"issue":"10","key":"10.1016\/j.urolonc.2024.07.017_bib0046","doi-asserted-by":"crossref","first-page":"e838","DOI":"10.1038\/cddis.2013.350","article-title":"Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment","volume":"4","author":"Sui","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.urolonc.2024.07.017_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109273","article-title":"Artesunate induces autophagy dependent apoptosis through upregulating ROS and activating AMPK-mTOR-ULK1 axis in human bladder cancer cells","volume":"331","author":"Zhou","year":"2020","journal-title":"Chem Biol Interact"},{"issue":"10","key":"10.1016\/j.urolonc.2024.07.017_bib0048","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1016\/j.apsb.2022.06.004","article-title":"Autophagy and beyond: unraveling the complexity of UNC-51-like kinase 1 (ULK1) from biological functions to therapeutic implications","volume":"12","author":"Zou","year":"2022","journal-title":"Acta pharmaceutica Sinica B"},{"issue":"10","key":"10.1016\/j.urolonc.2024.07.017_bib0049","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1080\/15548627.2020.1850609","article-title":"MAPK1\/3 kinase-dependent ULK1 degradation attenuates mitophagy and promotes breast cancer bone metastasis","volume":"17","author":"Deng","year":"2021","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.urolonc.2024.07.017_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1010428317698360","article-title":"Identification and validation of a novel autophagy gene expression signature for human bladder cancer patients","volume":"39","author":"Eissa","year":"2017","journal-title":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine"},{"issue":"2","key":"10.1016\/j.urolonc.2024.07.017_bib0051","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10549-012-2080-y","article-title":"Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients","volume":"134","author":"Tang","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.urolonc.2024.07.017_bib0052","unstructured":"Society AC. Key statistics for bladder cancer 2023. Available from: https:\/\/www.cancer.org\/cancer\/types\/bladder-cancer\/about\/key-statistics.html."},{"key":"10.1016\/j.urolonc.2024.07.017_bib0053","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2147\/JHC.S399855","article-title":"ULK1 depletion protects mice from diethylnitrosamine-induced hepatocarcinogenesis by promoting apoptosis and inhibiting autophagy","volume":"10","author":"Duan","year":"2023","journal-title":"Journal of hepatocellular carcinoma"},{"key":"10.1016\/j.urolonc.2024.07.017_bib0054","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fgene.2015.00157","article-title":"DNA repair mechanisms in cancer development and therapy","volume":"6","author":"Torgovnick","year":"2015","journal-title":"Front Genet"},{"issue":"20","key":"10.1016\/j.urolonc.2024.07.017_bib0055","doi-asserted-by":"crossref","first-page":"33704","DOI":"10.18632\/oncotarget.16734","article-title":"Ulk1 over-expression in human gastric cancer is correlated with patients' T classification and cancer relapse","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.urolonc.2024.07.017_bib0056","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5301\/JBM.2012.9769","article-title":"Expression of beclin 1 in bladder cancer and its clinical significance","volume":"28","author":"Liu","year":"2013","journal-title":"Int J Biol Markers"},{"issue":"1","key":"10.1016\/j.urolonc.2024.07.017_bib0057","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000486222","article-title":"Chloroquine enhances the radiosensitivity of bladder cancer cells by inhibiting autophagy and activating apoptosis","volume":"45","author":"Wang","year":"2018","journal-title":"Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology"},{"issue":"5","key":"10.1016\/j.urolonc.2024.07.017_bib0058","first-page":"5652","article-title":"Role of 5-Aza-CdR in mitomycin-C chemosensitivity of T24 bladder cancer cells","volume":"14","author":"Zhang","year":"2017","journal-title":"Oncol Lett"},{"issue":"3","key":"10.1016\/j.urolonc.2024.07.017_bib0059","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1590\/S1677-55382005000300003","article-title":"17-year follow-up of a randomized prospective controlled trial of adjuvant intravesical doxorubicin in the treatment of superficial bladder cancer","volume":"31","author":"Cheng","year":"2005","journal-title":"International braz j urol: official journal of the Brazilian Society of Urology"},{"issue":"2","key":"10.1016\/j.urolonc.2024.07.017_bib0060","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.3892\/etm.2020.8856","article-title":"Oblongifolin C reverses GEM resistance via suppressing autophagy flux in bladder cancer cells","volume":"20","author":"Huang","year":"2020","journal-title":"Experimental and therapeutic medicine"},{"issue":"11","key":"10.1016\/j.urolonc.2024.07.017_bib0061","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.3390\/cancers12113461","article-title":"Challenges and therapeutic opportunities of autophagy in cancer therapy","volume":"12","author":"Silva","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.urolonc.2024.07.017_bib0062","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.toxlet.2007.06.006","article-title":"Arsenic salts induced autophagic cell death and hypermethylation of DAPK promoter in SV-40 immortalized human uroepithelial cells","volume":"173","author":"Chai","year":"2007","journal-title":"Toxicol Lett"},{"issue":"8","key":"10.1016\/j.urolonc.2024.07.017_bib0063","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.tiv.2011.06.013","article-title":"para-Phenylenediamine-induced autophagy in human uroepithelial cell line mediated mutant p53 and activation of ERK signaling pathway","volume":"25","author":"Huang","year":"2011","journal-title":"Toxicology in vitro : an international journal published in association with BIBRA"},{"issue":"1","key":"10.1016\/j.urolonc.2024.07.017_bib0064","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12291-014-0446-0","article-title":"Free radicals: properties, sources, targets, and their implication in various diseases","volume":"30","author":"Phaniendra","year":"2015","journal-title":"Indian journal of clinical biochemistry : IJCB"},{"issue":"5","key":"10.1016\/j.urolonc.2024.07.017_bib0065","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/sj.bjc.6604915","article-title":"Relation between outcomes and localisation of p-mTOR expression in gastric cancer","volume":"100","author":"Murayama","year":"2009","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.urolonc.2024.07.017_bib0066","first-page":"862","article-title":"Immunohistochemical assessment of autophagic protein LC3B and p62 levels in glioma patients","volume":"11","author":"Jiang","year":"2018","journal-title":"International journal of clinical and experimental pathology"},{"issue":"12","key":"10.1016\/j.urolonc.2024.07.017_bib0067","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1158\/1078-0432.CCR-06-2940","article-title":"Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation study","volume":"13","author":"Dyrskjot","year":"2007","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"issue":"1","key":"10.1016\/j.urolonc.2024.07.017_bib0068","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1530\/JOE-19-0197","article-title":"Estrogen deficiency induces memory loss via altered hippocampal HB-EGF and autophagy","volume":"244","author":"Pandey","year":"2020","journal-title":"J Endocrinol"},{"issue":"7","key":"10.1016\/j.urolonc.2024.07.017_bib0069","doi-asserted-by":"crossref","first-page":"e69038","DOI":"10.1371\/journal.pone.0069038","article-title":"Aberrant expression of Beclin-1 and LC3 correlates with poor prognosis of human hypopharyngeal squamous cell carcinoma","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.urolonc.2024.07.017_bib0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141308","article-title":"Expression of beclin family proteins is associated with tumor progression in oral cancer","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.urolonc.2024.07.017_bib0071","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41379-021-00955-y","article-title":"Prediction of non-muscle invasive bladder cancer recurrence using machine learning of quantitative nuclear features","volume":"35","author":"Tokuyama","year":"2022","journal-title":"Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc"},{"key":"10.1016\/j.urolonc.2024.07.017_bib0072","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.613679","article-title":"The roles of beclin 1 expression in gastric cancer: a marker for carcinogenesis, aggressive behaviors and favorable prognosis, and a target of gene therapy","volume":"10","author":"Zheng","year":"2020","journal-title":"Front Oncol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924005702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924005702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:30:44Z","timestamp":1778797844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143924005702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":72,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1078143924005702"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.07.017","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of autophagy dysregulation in low and high-grade nonmuscle invasive bladder cancer: A survival analysis and clinicopathological association","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}